Biophore India Pharmaceuticals

Zenara Pharma launches the first generic of Paxlovid for COVID-19 in India

·   First company to launch the product in the country ·  Reduces the risk of death or hospitalization by 89%*…

2 years ago

Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment

Can market in India and 104 other countries Has also received DCGI regulatory license for Indian market Licenses applicable for…

3 years ago